Cutera Stock Forecast for 2023 - 2025 - 2030
Updated on 03/28/2024
Cutera Stock Forecast and Price Target
If Cutera's stock price reached the average yearlong target of $10.00 given by three well-known analysts in recent months, there would be a potential upside of approximately 395.05% from its last closing price in March, 2024. This potential increase is based on a high estimate of $10.00 and a low estimate of $3.00. If you're thinking of investing in CUTR stock, it might be good to look at its rivals too.
395.05% Upside
Cutera Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Cutera's Price has grown by 100.00%, from $0.00 to $0.00. For the next year, analysts are expecting Fair Value to reach $2.19 – an increase of 100.00%. Over the next seven years, experts predict that Fair Value will grow by 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
ABBV Stock Forecast | AbbVie | Outperform |
9
|
$179.63 | Buy/Sell | $178.42 | 0.21% |
ELF Stock Forecast | e.l.f. Beauty | Outperform |
16
|
$193.98 | Buy/Sell | $139.92 | 6.20% |
BHC Stock Forecast | Bausch Health Companies | Hold |
15
|
$9.12 | Buy/Sell | $9.50 | -1.32% |
INMD Stock Forecast | InMode | Outperform |
16
|
$21.54 | Buy/Sell | $35.40 | 39.28% |
UTMD Stock Forecast | Utah Medical Products | - |
18
|
$73.10 | Buy/Sell | $0.00 | -100.00% |
Cutera Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Cutera's Revenue has grown by 70.91%, from $147.68M to $252.40M. According to 6 major analysts, Cutera's Revenue will fall by 12.82% in the next year, reaching $220.05M. Over the next seven years, experts predict that Revenue will grow by 150.48%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
1696 Stock Forecast | Sisram Medical Ltd | Buy |
16
|
HK$3.94 | Buy/Sell | HK$1.26 | -68.02% |
FONR Stock Forecast | FONAR | - |
16
|
$22.17 | Buy/Sell | $0.00 | -100.00% |
APYX Stock Forecast | Apyx Medical | Outperform |
7
|
$1.74 | Buy/Sell | $4.67 | 72.41% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
VERO Stock Forecast | Venus Concept | Hold |
6
|
$0.78 | Buy/Sell | $10.60 | -100.00% |
AVGR Stock Forecast | Avinger | Outperform |
9
|
$3.31 | Buy/Sell | $5.00 | 51.06% |
BIOL Stock Forecast | BIOLASE | Buy |
0
|
$0.13 | Buy/Sell | $6.83 | 1823.08% |
Cutera EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Cutera's EBITDA has grown by 72.42%, rising from $-20.63M to $-35.57M. For next year, analysts predict EBITDA of $-49.78M, which would mean an increase of 39.95%. In 2030, professionals predict that Cutera's EBITDA will decrease by 145.55%, to $16.20M.
Cutera EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Cutera's EBIT has grown, rising from $-22.02M to $-38.19M – a growth of 73.43%. In the next year, analysts believe that EBIT will reach $-72.51M – an increase of 89.87%. For the next seven years, the forecast is for EBIT to grow by 19.22%.
Cutera EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Cutera's EPS has grown by 100.00%, from $-0.35 to $0.00. For the next year, analysts are expecting EPS to reach $-2.62 – an increase of 100.00%. Over the next seven years, experts predict that EPS will grow by 100.00%.